Ads
related to: newest sleep apnea treatment solutionscirclemedical.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
About 20 years after Sullivan’s CPAP discovery, Dr. Atul Malhotra began his career as a sleep apnea researcher. “I vowed to find new treatments,” says Malhotra, a sleep medicine specialist ...
Untreated sleep apnea can lead to serious health conditions. Moderate to severe sleep apnea can increase your risk of: High blood pressure. Heart failure. Cardiovascular disease. Stroke. Fatty ...
In clinical trials, GLP-1 drug tirzepatide reduced sleep apnea events by as much as two-thirds over the course of 52 weeks in patients with obstructive sleep apnea. Patients taking a placebo ...
Certain patients with obstructive sleep apnea who are deemed eligible candidates may be offered the hypoglossal nerve stimulator as an alternative. FDA-approved hypoglossal nerve neurostimulation is considered medically reasonable and necessary for the treatment of moderate to severe obstructive sleep apnea when all of the following criteria are met: [4]
According to the current American Academy of Sleep Medicine treatment guidelines, [1] oral appliances should be considered for patients with snoring or minor to moderate sleep apnea, or as an alternative to CPAP in non compliant patients with severe obstructive sleep apnea. Where appropriate, they are considered a good therapy choice as they ...
Somnoplasty [1] is a trademark by Somnus Medical Technologies [2] used for its radiofrequency ablation medical devices cleared by the Food and Drug Administration (FDA) to treat habitual snoring, chronic nasal obstruction, and obstructive sleep apnea (OSA) to shrink the tissues that are causing obstruction.
Ads
related to: newest sleep apnea treatment solutionscirclemedical.com has been visited by 10K+ users in the past month